Bio-Rad Laboratories Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Bio-Rad Laboratories, Inc. (BIO.B) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.490.400.430.470.66
Short-Term Investments1.181.201.360.400.33
Cash & Short-Term Investments1.661.611.790.870.99
Accounts Receivable0.450.490.510.420.42
Inventory0.760.780.720.570.62
Other Current Assets0.030.030.120.010.09
Total Current Assets3.033.053.161.992.14
Non-Current Assets
Property, Plant & Equipment (Net)0.690.720.680.720.69
Long-Term Investments4.847.708.8314.399.56
Goodwill0.410.410.410.350.29
Intangible Assets0.290.320.330.250.20
Other Non-Current Assets0.100.090.100.100.09
Total Non-Current Assets6.339.2510.3415.810.00
Total Assets9.3612.3013.5017.8012.97
Current Liabilities
Accounts Payable0.120.140.140.140.14
Short-Term Debt0.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.00
Accrued Liabilities0.120.140.190.280.26
Deferred Revenue0.000.000.050.050.04
Other Current Liabilities0.150.160.170.130.13
Total Current Liabilities0.470.520.570.680.63
Non-Current Liabilities
Long-Term Debt1.201.201.190.010.00
Deferred Tax Liabilities0.821.481.773.062.08
Other Non-Current Liabilities0.180.200.150.180.10
Total Non-Current Liabilities2.333.043.323.430.00
Total Liabilities2.793.563.894.113.09
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings7.429.269.9013.539.27
Accumulated Other Comprehensive Income-0.54-0.34-0.47-0.180.28
Treasury Stock0.770.630.260.110.00
Additional Paid-in Capital0.460.450.450.440.00
Shares Outstanding0.030.030.030.030.00
Total Stockholders' Equity6.578.749.6213.699.88
Total Liabilities & Equity9.3612.3013.5017.800.00